|
Disease |
|
|
|
Detail |
| hsa-let-7a |
|
Causal |
MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. |
2007 |
|
|
|
|
|
|
| hsa-miR-17-92 |
|
Causal |
Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. |
2007 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Causal |
Downregulation of microRNAs-143 and -145 in B-cell malignancies. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Downregulation of microRNAs-143 and -145 in B-cell malignancies. |
2007 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. |
2004 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. |
2005 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. |
2007 |
|
|
|
|
|
|
| hsa-let-7c |
|
Causal |
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
|
2008 |
|
|
|
|
|
|
| hsa-miR-34b |
|
Causal |
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
|
2008 |
|
|
|
|
|
|
| hsa-miR-26a |
|
Causal |
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. |
2008 |
|
|
|
|
|
|
| hsa-miR-127 |
|
Unspecified |
B cell differentiation in EBV-positive Burkitt Lymphoma is impaired at post-transcriptional level by miRNA altered expression. |
2009 |
|
|
|
|
|
|